The elevated levels of CD137 observed in individuals with active TB compared to those latently infected suggest its potential as a biomarker for TB diagnosis and severity when measured as a soluble marker or as a cell surface marker on T cells. This evidence concerns the gene TNFRSF9 and tuberculosis.